BEHANDLUNGSOPTIONEN FÜR MORBUS FABRY

Patent europeic · EP3457135 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3457135
Numer da la dumonda
EP18197135
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
16-05-2007
Publitgà
20-03-2019
Concedì
04-12-2024
La protecziun finescha il pli tard
15-05-2027
Proxima taxa annuala scadenta
31-05-2027
Classas IPC
G01N 33/53 (2006.01)
C07D 211/46 (2006.01)
A61K 45/06 (2006.01)
A61K 31/445 (2006.01)
A61P 9/00 (2006.01)
A61P 13/12 (2006.01)
Prioritad
US 801089 P 16.05.2006
US 853631 P 23.10.2006
Derivà da
EP15173515
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-06-2026

    Midada

    Published in Swissreg on 01.06.2026

  2. 15-10-2025

    Midada

    Published in Swissreg on 15.10.2025

  3. 01-06-2025

    Midada

    Published in Swissreg on 01.06.2025

  4. 04-12-2024

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 04.12.2024

Partidas

Possessur

AMICUS THERAPEUTICS, INC.

Amicus Therapeutics, Inc.

3675 Market Street, Philadelphia, PA 19104, US

National Institutes of Health

NATIONAL INSTITUTES OF HEALTH

10 Center Drive, Bethesda MD 20892-1260, US

Inventur

LOCKHART, David

Cranbury, NJ 08512, US

CASTELLI, Jeff

Cranbury, NJ 08512, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.